Effect of Combined Intra-articular Injection of Lidocaine Plus Physiotherapy in Treatment of Frozen Shoulder

October 27, 2016 updated by: Shin Kong Wu Ho-Su Memorial Hospital
  1. Therapeutic exercise, especially stretch exercise and joint mobilization, remain the mainstay of conservative treatment of frozen shoulder.

    1. Nevertheless, shoulder pain during the physiotherapy reduces the treatment effect.
    2. Manipulation or arthroscopic release under general anesthesia may avoid pain during the intervention; however, increased risk of humeral shaft fracture and failure of release of pathological tissue were reported.
  2. We consider intra-articular injection is a compromized way, from a practical point of veiw, to reduce the pain during physiotherapy.
  3. We hypothesize that, intra-articular injection with lidocaine before joint mobilization and stretch exercise, can make the patient pain-free during physiotherapy, and the effect of combined therapy is superior to physiotherapy alone in the treatment of frozen shoulder.

Study Overview

Detailed Description

A randomized controlled trial to compare the effect in treatment of frozen shoulder between combined intra-articular injection with lidocaine plus physiotherapy and physiotherapy alone.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Shin Kong Wu Ho-Su Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinically diagnosed as unilateral frozen shoulder, with the definition as more than 50% loss of passive movement of the shoulder joint relative to the non-affected side, in one or more of the three movement direction (ie. abduction in the frontal plane, forward flexion in sagittal plane, or external rotation in 0 degree of abduction)
  • Duration of complaints of more than three months
  • Ability to complete questionnaires in Chinese

Exclusion Criteria:

  • History of shoulder fracture, dislocation, or trauma
  • History of Rheumatic arthritis, tumor, or other diseases in the shoulder joints
  • Receive intra-articular corticosteroid injection or manipulation therapy in shoulder joint in recent four weeks
  • Pregnancy or breast feeding
  • Allergic to lidocaine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lidocaine group

1% lidocaine 5ml intra-articular injection to shoulder joint + physiotherapy three times weekly

  • Injection is performed if pain during intervention equals to or greater than 7cm in a 10-cm VAS scale.
  • Injection frequency is not greater than twice per week and total injection time is limited to 10 times in the whole course
  • In each week, patient will receive 3 times of PT with or without intra-articular lidocaine injection.
  • Patient position: prone position with arm under the abdomen and the elbow flexed to a right angle
  • Injection with a 25-gauge, 1.5-inch long needle fitted with 3ml syringe filled with 3ml 1% lidocaine.
- Include electric therapy, hot pack, followed by stretch exercise and joint mobilization
Other Names:
  • Physiotherapy
Placebo Comparator: PT group
- Apply to every patient, each by the same physical therapist, 3 times weekly for 3 months or till the patients gain satisfactory results.
- Include electric therapy, hot pack, followed by stretch exercise and joint mobilization
Other Names:
  • Physiotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in range of motion at 3-months intervention
Time Frame: baseline; 1 month; 2 months; 3 months
  • Measured with a conventional goniometer by a physiotherapist, both active and passive range of motion
  • Including shoulder flexion, abduction, internal rotation, and external rotation
  • All measurements will be rounded off to the nearest five degrees
baseline; 1 month; 2 months; 3 months
Change from Baseline in range of motion at 3 months post-intervention
Time Frame: baseline; 1 and 3 months after completion
  • Measured with a conventional goniometer by a physiotherapist, both active and passive range of motion
  • Including shoulder flexion, abduction, internal rotation, and external rotation
  • All measurements will be rounded off to the nearest five degrees
baseline; 1 and 3 months after completion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analog scale (VAS)
Time Frame: baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion
  • Horizontal lines of 100mm, with 0 indicating no pain on the left and 100 indicating very severe pain on the right
  • Three separate visual analog scales: shoulder pain at rest, during movement, and during the night
baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion
36-Item Short-form health survey (SF-36)
Time Frame: baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion
  • General health status measurement
  • 8 subscales for physical functioning, social functioning, role limitations (physical problems, emotional problems), mental health, vitality, pain, and general health perception
  • Each subscale generates a score from 0 to 100, with higher score indicating better health
baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion
Shoulder Rating Questionnaire (SRQ)
Time Frame: baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion
  • Self-administered questionnaire
  • Include global assessment, pain, daily activities, recreational and athletic activities, work, satisfaction, and areas for improvement.
  • Total score ranges from a minimum of 17 points (worst) to a maximum of 100 points (best functional status)
baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion
Shoulder Disability Questionnaire (SDQ)
Time Frame: baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion
  • For shoulder disability measurement
  • Consists of 23 symptoms that participants respond to with either "yes" or "no" or "not applicable"
  • Score ranges from 0 to 100, is the number of positive response divided by the number of answered questions multiplied by 100.
baseline; 1 month; 2 months; 3 months; 1 and 3 months after completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lin-Fen Hsieh, M.D., Shin Kong Wu Ho-Su Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

February 1, 2014

Study Registration Dates

First Submitted

January 8, 2013

First Submitted That Met QC Criteria

March 20, 2013

First Posted (Estimate)

March 25, 2013

Study Record Updates

Last Update Posted (Estimate)

October 28, 2016

Last Update Submitted That Met QC Criteria

October 27, 2016

Last Verified

October 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Capsulitis

Clinical Trials on Lidocaine group

3
Subscribe